Neuroblastoma is divided into risk groups based on criteria which include: the age of the patient at diagnosis, International Neuroblastoma Risk Group (INRG) tumour stage and MYCN copy number status (Cohn et al., 2009; Monclair et al., 2009). The gene discussed is MYCN; the disease is neoplasm.